Perbak Capital Partners LLP
Source: SEC Form 13F · as of Mar 2026Perbak Capital Partners LLP holds 23 biotech & pharma companies tracked by BioSniper, totaling $12.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
23
Total value held
$12.6M
| Company | Shares | Value |
|---|---|---|
| ALKSAlkermes plc. | 31,185 | $1.1M |
| MOHMolina Healthcare Inc | 7,755 | $1.0M |
| ICUIICU Medical Inc. | 7,631 | $986K |
| REGNREGENERON PHARMACEUTICALS, INC. | 1,205 | $931K |
| UTHRUNITED THERAPEUTICS Corp | 1,438 | $853K |
| GILDGILEAD SCIENCES, INC. | 5,968 | $832K |
| DVADaVita Inc. | 5,358 | $823K |
| MEDPMedpace Holdings Inc. | 1,396 | $670K |
| MRNAModerna, Inc. | 10,991 | $558K |
| KYMRKymera Therapeutics, Inc. | 6,443 | $537K |
| AXSMAxsome Therapeutics, Inc. | 3,058 | $517K |
| GEHCGE HealthCare Technologies Inc. | 5,941 | $423K |
| SHCSotera Health Company | 28,363 | $407K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,205 | $399K |
| CAICaris Life Sciences Inc. | 22,001 | $393K |
| CORTCORCEPT THERAPEUTICS INC | 9,709 | $391K |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | 6,754 | $349K |
| PRAXPraxis Precision Medicines, Inc. | 799 | $257K |
| CPRXCATALYST PHARMACEUTICALS, INC. | 10,337 | $256K |
| DNLIDenali Therapeutics Inc. | 13,175 | $253K |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 3,657 | $229K |
| TGTXTG THERAPEUTICS, INC. | 6,443 | $214K |
| ADPTAdaptive Biotechnologies Corp | 12,645 | $176K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.